Screening campaigns urge Kenyans to catch cancer early, but with treatment costs running into millions of shillings, families need financial protection to turn a diagnosis into a chance at survival.
Every year, Kenyans are reminded that early detection saves lives. Women are encouraged to seek appropriate breast and cervical cancer screening, while men are urged to understand their prostate cancer risks and discuss recommended testing with healthcare professionals.
These messages remain essential. But as we transition from Breast Cancer Awareness Month in October to Prostate Cancer Awareness Month in November, we must confront another uncomfortable reality: what happens when cancer is detected, but a family cannot afford the treatment needed to fight it?
For thousands of Kenyan families, a cancer diagnosis is not only a medical emergency; it can become a financial crisis that threatens household savings, livelihoods, and long-term security.
According to the International Agency for Research on Cancer, Kenya recorded an estimated 7,243 new breast cancer cases in 2022. Prostate cancer was the most commonly diagnosed cancer among Kenyan men, accounting for 21.9 per cent of new cancer cases in males, with an estimated 2,029 deaths.
Behind these statistics are individuals balancing treatment with employment, caregiving responsibilities and the everyday costs of supporting their families.
The financial burden can be substantial. A 2026 study involving 103 breast cancer patients at Kenyatta National Hospital estimated average total household costs at approximately Ksh2.14 million, including direct medical expenses, transport, other non-medical costs and lost income.
Perhaps more troubling is how families cope. The study found that 97 per cent of participants relied on personal income and savings, 29 per cent sold assets, and 22 per cent took loans to meet treatment-related costs.
These findings raise an important question: can we truly call early detection a success if patients cannot afford to start treatment?
Early diagnosis improves the prospects of successful treatment. However, its benefits can be undermined when patients delay appointments, struggle to access prescribed medicines or interrupt treatment because of financial difficulties.
Health insurance is an important part of this equation, helping families manage eligible treatment expenses and protect household savings, yet having insurance does not necessarily mean being adequately protected. Families must understand their benefits, coverage limits, exclusions and potential gaps, particularly when serious illness brings additional expenses such as transport, caregiving and lost income.
The financial vulnerability of Kenyan households is further underscored by the latest 2025–26 Kenya Mini Demographic and Health Survey, published by the Kenya National Bureau of Statistics (KNBS). The survey found that approximately 40 per cent of the household population had some form of health insurance, meaning most households had none. This highlights a significant protection gap for families facing costly and prolonged illnesses such as cancer.
These findings reflect a wider challenge in healthcare financing. A 2022 World Bank report on Kenya’s health expenditure highlighted the substantial burden of out-of-pocket healthcare payments, citing estimates that medical expenses were pushing approximately one million Kenyans into poverty annually.
Together, these findings demonstrate that financial protection cannot be an afterthought in cancer care.
Yet financial preparedness is often framed primarily as a household responsibility. We encourage families to save, plan for emergencies and obtain appropriate insurance. While these are important steps, how many households can realistically prepare for treatment costs running into millions of shillings?
The responsibility must therefore extend beyond individual families.
For the insurance industry, this means making healthcare protection more accessible, understandable and responsive to the realities of prolonged illness. It also means helping customers understand the difference between having health cover and having sufficient financial protection when they need it most.
Healthcare providers should initiate conversations about treatment costs early, identifying patients at risk of financial distress and connecting them with available support before financial pressures disrupt care.
Employers also have a role to play through flexible working arrangements, supportive leave policies and employee wellness programmes that recognise the physical, emotional and financial pressures associated with cancer treatment.
Equally, policymakers must continue strengthening healthcare financing systems to reduce out-of-pocket costs and improve continuity of care.
Ultimately, as one awareness month gives way to another, the national conversation must evolve beyond encouraging men and women to seek screening. We must also ask whether our healthcare financing systems are helping those diagnosed to access and complete treatment without compromising their families’ financial futures.
Early detection offers patients a better chance of survival. Affordable, continuous treatment helps turn that chance into reality.
Emily Nazi is the Assistant Wellness Manager at Jubilee Health Insurance.
We believe in the free flow of information
Republish our articles for free, online or in print, under Creative Commons licence.








